Watch our latest #DigitalHealth Monthly Webinar on-demand to hear results from the ADDS 2025 #ALS Workshop, details about new digital measures in ALS, and an insightful panel discussion about how to unlock to potential of DHTs to advance ALS clinical trials: ametris.com/digital-heal...

Please join our upcoming #DigitalHealth Monthly webinar - Redefining #ALS Clinical Endpoints: Unlocking the Potential of #DHTs - where a diverse panel of stakeholders will explore strategies for advancing #digitalendpoints in ALS research: ametris.com/digital-heal...

Registration is now open for the Ametris Digital Data Summit 2026! 🚨 NEW THIS YEAR! For select abstracts submitted to the Scientific Poster Session, there will be an opportunity for a short oral presentation (5-7 minutes). We hope to see you in Atlanta! #ADDSATL2026 adds.ametris.com/2026/atlanta...

How AI-Driven Continuous Monitoring Can Improve Management of Immunotherapy-Related Cytokine Release Syndrome in Oncology Patients | Applied Clinical Trials Online Remote monitoring solution for cytokine release syndrome paves the way for more consistent patient care, a deeper understanding of immune responses, ultimately widening patient access to life-saving i...

📣 We're excited to share a new article by Ametris' Chief Scientific Officer, Christine Guo:

How AI-Driven Continuous Monitoring Can Improve Management of Immunotherapy-Related Cytokine Release Syndrome in Oncology Patients

Read here: www.appliedclinicaltrialsonline.com/view/ai-immu...

Register for #DigitalHealth Monthly #webinar THIS THURSDAY, 9/18, to learn about #DECODE #Obesity working group focusing on evidence generation & regulatory engagement to enhance clinical programs with mature assessments of #physicalactivity ➡️ametris.com/digital-health-monthly/d...

Scientific Poster Session | ADDS Atlanta 2026 ADDS Atlanta 2026 Scientific Poster Session!

📣 Call for Abstracts!

We can't wait for the next opportunity to connect with the #digitalhealth community at #ADDSAtlanta2026 on Feb 23-25. We hope you will share your work at the Scientific Poster Session!

📆 Submit your abstract by Friday, October 31st, 2025: adds.ametris.com/2026/atlanta...

↪️ #ADDSBasel2025 is right around the corner! Have you secured your ticket? Connect with #digitalhealth researchers to accelerate #DHT adoption in #clinicalresearch. Spots are filling up! Reserve your ticket and register today: adds.ametris.com/2025/basel/h...

Association of sensory and motor impairments with dementia: a cross-sectional analysis in US older adults - BMC Geriatrics Background Impairments in sensory and motor function are common in older adults and have been linked with higher prevalence of dementia. However, their independent associations with dementia have not ...

New publication from the National Health and #Aging Trends Study (#NHATS) reports that impairment in vision or motor function may be strong indicators of prevalent #dementia in older adults: bmcgeriatr.biomedcentral.com/articles/10....

Grant Toolkit | Ametris This toolkit is designed to facilitate the application submission process by gathering information in one place for quick and convenient access.

📑 Are you applying for #grantfunding and using #actigraphy / #wearables / #digitalhealth tech in your study? Check out our new toolkit, Grant Preparation Resources for Wearable-Based Studies, where we gather commonly requested information in one place: landing.ametris.com/grant-toolkit

🔎 Have you seen the #ADDSBasel2025 agenda yet? Watch the short video below to hear what makes ADDS such a unique opportunity to bring members of the multidisciplinary #digitalhealth community together in Basel on Sept. 12th! Learn more and register today▶️ adds.ametris.com/2025/basel/h...

🎥 Our latest #DigitalHealth Monthly webinar is available on-demand! Panelists discussed key points & lessons learned based on their experiences with #wearable #DHTs to help researchers submit compelling, high-impact #grantproposals. Watch here▶️ametris.com/digital-health-monthly/g...

Characteristics of Daily Walking Bouts as Valid and Reliable Indicators of Exercise Capacity in Pulmonary Arterial Hypertension: Insights From the Randomized Controlled Study With Selexipag (TRACE) There is a need for objective, continuous and remote assessment of exercise capacity in patients with pulmonary arterial hypertension (PAH). Using data from the TRACE study, in which 108 adult patien...

TRACE study found wrist-worn #actigraphy measured walking bouts in patients w/ #Pulmonary Arterial Hypertension correlate with 6MWD & physical impacts of #PAH, speaking to the utility of #digitalmeasures to monitor #exercisecapacity
@pvrinstitute.bsky.social onlinelibrary.wiley.com/doi/10.1002/...

✨ The #ADDSBasel2025 Agenda is now available! ✨The schedule includes scientific presentations, case studies, & panels across four main session topics - #Oncology, #Neurology, #TechnicalValidation, & #RegulatoryPathways
🔗https://adds.ametris.com/2025/basel/home#agenda
#DigitalHealth #DigitalData

Grant Planning for Wearable-Based Research: Insights and Best Practices | Ametris Explore data-driven health insights with 'Digital Health Monthly' webinar series. Join expert panels to uncover digital health advancements. Register now!

Register for our #DigitalHealthMonthly webinar, Grant Planning for #Wearable-Based Research: Insights & Best Practices! We invite #academic, #publichealth, and #clinicalresearchers to join as we share lessons learned for incorporating #actigraphy into #grant applications: ametris.com/digital-heal...

📣 The evolution is here: #ActiGraph is now #Ametris! Reflecting the transformation from our foundation in #actigraphy into a global #digitalhealth solutions provider. Same Team. Same Mission. Greater Impact. Read the announcement: blog.theactigraph.com/news/actigra...

📣 Join us for #DigitalHealthMonthly #webinar where #digitalhealth experts from Pfizer, J&J, and Novartis will discuss the unique challenges of #adherence & nuances of collecting #wearable #DHT-based data in #clinicaltrials🔗
Register here: theactigraph.com/digital-heal...

Comparing Five Generations of ActiGraph Devices Using an Orbital Shaker - PubMed Using an orbital shaker and criterion accelerometer, we found small differences in the raw output of five ActiGraph generations across a range of accelerations typical of free-living data. However, th...

This new publication provides an objective validation of five generations of #ActiGraph sensors for researchers using these #wearables to measure #physicalactivity #sedentarybehavior & #sleep: All devices largely fell within established limits of agreement -> pubmed.ncbi.nlm.nih.gov/39819800/

Identification of passive wrist-worn accelerometry outcomes for improved disease monitoring and trial design in motor neuron disease Wrist-worn accelerometry offers a practical solution for continuous monitoring in MND, complementing ALSFRS-R. Measures of peak performance, and specifically peak 6-min activity shows promise, potenti...

This @ebiomedicine.bsky.social paper assesses & validates wrist-worn #accelerometry measures in #ALS. Peak 6-min activity -
✴️ demonstrated functional decline
✴️ captured unique aspects of disease impact
✴️ predicted smaller trial sample sizes for long-term studies www.thelancet.com/journals/ebi...

ActiGraph is excited to be at #ACSM2025 this week! ✳️ If you're attending the #Aging Interest Group meeting, we'll be presenting later today, Wed, 5/28 at 6:00pm in CC-C208 - please stop by the #ActiGraph table to connect about how #wearables can support your #research!

📣 Call for Abstracts! 📣 We invite you to submit your research using #wearable #DHTs to #ADDSBasel2025 #scientificposter session by Jul. 27th!

Learn what previous presenters had to say about their experience below! More details & link to submit your #abstract: adds.theactigraph.com/2025/basel/s...

Physical Activity Patterns and Variability, Cognitive... : Medicine & Science in Sports & Exercise S. Medicare beneficiaries. Dementia status (dementia vs. no dementia) was classified per NHATS protocol. Cognitive performance was assessed in executive function, orientation, and memory domains. Dail...

@jenschrack.bsky.social & colleagues recently published findings from the #NHATS study that #dementia was associated with lower volume & intensity of daily #physicalactivity, highlighting the need to consider physical activity accessibility and patterns as we age - journals.lww.com/acsm-msse/ab...

Perspectives of Key Stakeholders on Integrating Wearable Sensor Technology into Rehabilitation Care: A Mixed-Methods Analysis Introduction Rehabilitation is facing a critical practice gap: Patients seek out rehabilitation services to improve their activity in daily life, yet recent work demonstrates that rehabilitation may b...

This @uwsom-wwami.bsky.social study explores integrating #wearables into outpatient #rehabilitation, finding 63% of clinicians prefer continuous monitoring, 60% of patients are willing to sync sensor data & clinicians favor #EHR integration for seamless workflow:

www.medrxiv.org/content/10.1...

Visit our 📚 Patient-Focused #DigitalMeasures Library to learn how #wearable #DHTs can capture data on the functions that patients' report are most impacted by #respiratory disease symptoms, including #physicalactivity, #sleep, #cough & #vitalsigns
🔗 theactigraph.com/patient-focu...

DHM Webinar: The Value of Continuous Cough Monitoring | ActiGraph Explore data-driven health insights with 'Digital Health Monthly' webinar series. Join expert panels to uncover digital health advancements. Register now!

Please join #ActiGraph & @hyfe.com for the upcoming #DigitalHealth Monthly #webinar discussing a new #wearable solution for #cough monitoring in the real world! Don't miss this opportunity to gain insights into cutting-edge #respiratorydisease research.
👉 Register: theactigraph.com/digital-heal...

Physical Activity and Sedentary Behavior as Treatable Traits for Clinical Control in Moderate-to-Severe Asthma - PubMed Our results show that ≥7500 steps/day is associated with better asthma control independent of sedentary time in adults with moderate-to-severe asthma. Physical inactivity, anxiety, and depression symp...

Researchers report higher #wearable -measured daily step count is associated with better #asthma control independent of sedentary time, suggesting interventions should focus on increasing #physicalactivity in this Journal of Clinical Allergy & Immunology paper - pubmed.ncbi.nlm.nih.gov/38492665/

Actigraphy, a valuable tool for objective sleep evaluation in psoriasis: a review - Archives of Dermatological Research Psoriasis, a form of chronic inflammatory skin disease, shows wide variations in severity and comorbidities. Considering the relatively clear scientific evidence concerning its great physical and psyc...

"From the studies reviewed, a consistent theme emerges: #actigraphy serves as a powerful, minimally invasive tool to capture changes in #sleep architecture among individuals living with #psoriasis." Learn more in this new systematic review:
link.springer.com/article/10.1...

Validation and accuracy of the Hyfe cough monitoring system: a multicenter clinical study - Scientific Reports Scientific Reports - Validation and accuracy of the Hyfe cough monitoring system: a multicenter clinical study

#Digitalhealth tech can transform how we measure symptoms to help researchers capture more accurate, comprehensive, & real-world view of health, including a symptom that is often overlooked & under researched – #cough. Read more in this new paper from @hyfe.com: www.nature.com/articles/s41...

#Sleep is a critical aspect of health. #Wearables are effective, non-invasive tools for real-world assessments. This poster from the #ActiGraph science team leverages #NHANES data for an automated approach to detect outlier sleep periods; improving QC & uncovering new sleep insights: bit.ly/3RzyOIw

Our latest paper using @actigraph.bsky.social accelerometers and @staroddi.bsky.social biologgers in Comparative Biochemistry & Physiology Part A

Ponsegromab for the Treatment of Cancer Cachexia | NEJM Cachexia is a common complication of cancer and is associated with an increased risk of death. The level of growth differentiation factor 15 (GDF-15), a circulating cytokine, is elevated in cancer ...

A recent Phase 2 study in #cancer #cachexia reported increased body weight, improved appetite, and increased #digitalmeasures of #physicalactivity. #Wearables captured key evidence to help evaluate the impact of a possible new treatment in this multifaceted condition - www.nejm.org/doi/full/10....